Protagonist Therapeutics, Inc. PTGX
Regular-session close
After hours · Nov 20, 4:00 PM ET
- YTD
- +39.00%
- 1 year
- +44.18%
Held by funds
199 US ETFs and mutual funds hold PTGX · largest positions
- IJR 0.50% of fund $526.12M
- NIR 0.36% of fund $370.90M
- VTI 0.01% of fund $234.39M
- IWM 0.28% of fund $215.27M
- VB 0.12% of fund $210.14M
- VGHCX 0.46% of fund $175.21M
- VEXRX 0.65% of fund $143.57M
- XBI 1.35% of fund $136.95M
- NJM 0.16% of fund $130.52M
- VBK 0.27% of fund $117.64M
- VXF 0.11% of fund $106.31M
- FSSNX 0.29% of fund $99.53M
- FBIOX 1.41% of fund $84.41M
- IWO 0.56% of fund $77.88M
- SPSM 0.49% of fund $77.73M
- IJT 1.03% of fund $76.38M
- XSMO 2.81% of fund $75.89M
- AFTY 2.28% of fund $72.72M
- ANOIX 1.25% of fund $64.21M
- IBB 0.57% of fund $62.66M
Ownership
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 16.45% | 10,734,300 | 1.30B | Sep 29, 2026 |
| Farallon Capital Management LLC | 9.86% | 6,437,906 | 781.56M | Sep 29, 2026 |
| RTW Investments LP | 7.75% | 5,061,175 | 614.43M | Sep 29, 2026 |
| UBS Group AG | 6.06% | 3,953,236 | 479.92M | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 5.62% | 3,668,478 | 445.35M | Sep 29, 2026 |
| Wellington Management Group, LLP | 5.43% | 3,543,702 | 430.21M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.91% | 3,854,840 | 467.98M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.13% | 2,044,938 | 248.26M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.44% | 1,594,175 | 193.53M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.26% | 1,475,422 | 179.12M | Jun 29, 2026 |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 1.91% | 1,243,618 | 150.98M | Jul 30, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.55% | 1,013,552 | 123.05M | Sep 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs PTGX, and what each was last paid
Dinesh V. Patel, Chief Executive Officer, President, Secretary & DirectorAverage age 60
| Name | Title | Pay | Age |
|---|---|---|---|
| Dinesh V. Patel | Chief Executive Officer, President, Secretary & Director | $1.41M | 69 |
| Arturo Molina FACP | Chief Medical Officer | $950K | 67 |
| Asif Ali | Executive Vice President & Chief Financial Officer | $826K | 52 |
| Carter J. King | Executive Vice President of Business Development | — | 55 |
| Matthew Gosling | Executive Vice President and Chief Legal & Business Officer | — | 55 |
| Venkat Thalladi | EVP & Chief Technical Officer | — | — |
| Abha Bommireddi | Executive Vice President & Chief of Staff | — | — |
| Carena Spivey | Executive VP & Chief Human Resources Officer | — | — |
| Newman Yeilding | Executive Vice President, Chief Scientific Officer | — | — |
| Ashok Bhandari | EVP & Chief Discovery Officer | — | 62 |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALI ASIF | Chief Financial Officer | Sale | Apr 19, 2026 | 59,003 |
| GIRAUDO BRYAN M. | Director | Sale | May 7, 2026 | 0 |
| GUPTA SUNEEL | Officer | Conversion of Exercise of derivative security | Nov 25, 2024 | 267,433 |
| MOLINA ARTURO MD | Officer | Sale | Nov 15, 2026 | 81,397 |
| O DOWD SARAH A | Director | Stock Award(Grant) | Jan 1, 2026 | 7,825 |
| PATEL DINESH V | Chief Executive Officer | Conversion of Exercise of derivative security | Sep 9, 2026 | 522,968 |
